Baird Financial Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,357
| Closed | -$90.8K | – | 1723 |
|
|
2023
Q2 | $90.8K | Buy |
+12,357
| New | +$90.8K | ﹤0.01% | 1657 |
|
|
2022
Q3 | – | Sell |
-8,192
| Closed | -$254K | – | 1735 |
|
|
2022
Q2 | $254K | Buy |
8,192
+879
| +12% | +$27.3K | ﹤0.01% | 1612 |
|
|
2022
Q1 | $300K | Buy |
7,313
+607
| +9% | +$24.9K | ﹤0.01% | 1614 |
|
|
2021
Q4 | $292K | Buy |
6,706
+3
| +0% | +$131 | ﹤0.01% | 1688 |
|
|
2021
Q3 | $336K | Buy |
+6,703
| New | +$336K | ﹤0.01% | 1625 |
|